The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Whole-Genome Sequencing v. Gene Patents: The Coming Showdown" on Wednesday, November 3, 2010 beginning at 2:00 PM (ET). The IPO webinar will address the question: when sequencing all or a portion of an individual's genome, are individual gene patents infringed upon by either the company providing the sequence, a company selling software to analyze the sequence, or the individual purchasing or requesting it? The webinar will also look at who the direct infringer would be, and whether someone would be liable for indirect infringement. The speakers include Patent Docs author Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff LLP; Ned Israelsen of Knobbe Martens Olson & Bear, LLP; and Ken Chahine of the University of Utah. The registration fee for the webinar is $100 (government and academic rates are available upon request). Those interested in registering for the webinar, can do so here.
Contributors
Juristat #4 Overall Rank
Contact the Docs
Foreign Correspondents
Recent Posts
- Wisconsin Alumni Research Foundation v. Apple Inc. (Fed. Cir. 2024)
- Special Committee's Suspension Recommendation Adopted by Federal Circuit
- Natera, Inc. v. NeoGenomics Laboratories, Inc. (Fed. Cir. 2024)
- Andersen v. Stability AI: Defendants' Motion to Dismiss Narrows the Case, But Only Slightly
- Ryan LLC v. FTC: Texas Federal Court Strikes Down FTC's Prohibition on Non-Competes
- ABA Issues Formal Ethics Opinion on Use of Generative AI Tools
- United Therapeutics Corp. v. Liquidia Technologies Inc. (Fed. Cir. 2024)
- 91%: That is the Rate at Which the PTAB Affirms Examiner Section 101 Rejections
- Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc. (Fed. Cir. 2024)
- The NO FAKES Act: Bipartisan Group of Senators Introduce Bill to Protect against Unauthorized Uses of Digital Replicas
Disclaimer
- "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank
- Powered By Invesp
« IQPC Offers Podcast on Polymorph Patents | Main | PTO Day »
October 29, 2010
Comments
The comments to this entry are closed.
September 2024
Categories
- Artificial Intelligence (19)
- Best Mode (2)
- Biosimilars (247)
- Biotech/Pharma Business (175)
- Biotech/Pharma News (277)
- Board of Patent Appeals and Interferences (12)
- Claim Construction (104)
- Conferences & CLE's (2977)
- Copyright (4)
- Court Report (507)
- Damages (37)
- Definiteness (26)
- District Court (222)
- Double Patenting (37)
- Enablement (52)
- Federal Circuit (1015)
- Food and Drug Administration (109)
- Hatch-Waxman (93)
- Inequitable Conduct (52)
- Infringement - Contributory or Induced (28)
- Infringement - Literal or DOE (91)
- Injunction (34)
- International IP (297)
- Inventorship (17)
- Licensing (129)
- Media Commentary (71)
- Miscellaneous (168)
- News from Abroad (102)
- Novelty (73)
- Obviousness (232)
- Patent Exhaustion (3)
- Patent Legislation (312)
- Patent Litigation (217)
- Patent Office Rules & Procedures (827)
- Patent Profiles (104)
- Patent Prosecution (99)
- Patent Prosecution - International (26)
- Patent Research (4)
- Patent Trial and Appeal Board (368)
- Patentable Subject Matter (643)
- Personalized Medicine (5)
- Post-Grant Proceedings (158)
- PTAB Report (9)
- Study/Report (7)
- Supreme Court (262)
- Tools (5)
- Trade Secrets (13)
- Utility (4)
- Venue (11)
- Written Description (88)
Patent Resources
Patent Search
- Patent Search
Patent Blogs & Sites
- 717 Madison Place
- America-Israel Patent Law
- Anticipate This!
- BlawgIT
- Chicago IP Litigation Blog
- FedCircuitBlog
- Global Patent Quality
- Innovation Alliance
- Intellectual Property Watch
- IP Dragon
- IPcopy
- McCabe Ali LLP
- IPWatchdog.com
- Life Science IP
- Orange Book Blog
- Patent Blurb
- Patently-O
- Patentology
- Patents4Life
- Reexamination Center
- Intellepedia – IP News Center
- SPICY IP
Hot off the presses, a NY Times article where Feds say they don't think Genes should be patentable. Friend of Court brief filed in BRCA decision
http://www.nytimes.com/2010/10/30/business/30drug.html?_r=2&hp
Posted by: bigredbruce | October 30, 2010 at 09:57 AM
big day in gene patenting, Kevin:
http://www.nytimes.com/2010/10/30/business/30drug.html?_r=2&hp
That ought to provide some fodder for the seminar.
Posted by: David Koepsell | October 30, 2010 at 11:41 AM
The DOJ's recently-issued brief opposing gene patents, in tandem with the Myriad appeal, will likely alter the dynamics of these questions. Sounds like an interesting discussion, though.
http://www.generalpatent.com/media/videos/patent-suits
Posted by: patent litigation | November 02, 2010 at 12:09 AM